| Literature DB >> 7894536 |
C M van Rijn1, E W Weyn Banningh, A M Coenen.
Abstract
Lamotrigine, a novel antiepileptic drug thought to inhibit the excitatory neurotransmitter release and indicated for convulsive seizures, was tested for its efficacy in modulating non-convulsive seizures of the absence type of epilepsy. This was done in a rat model for absence epilepsy: the WAG/Rij strain of rats. In side-effect free doses, lamotrigine did not inhibit absence seizures in these animals. Only in a high dose a reduction of spike-wave activity was noticed, but in that dose side-effects such as abnormal locomotion, were also seen. These findings underline the differential pharmacological profile of convulsive and non-convulsive generalized epilepsy.Entities:
Mesh:
Substances:
Year: 1994 PMID: 7894536
Source DB: PubMed Journal: Pol J Pharmacol ISSN: 1230-6002